Ampudia-Mesias, E., Moertel, C., & Olin, M. (2017). IMMU-02. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT: A NEW DIRECTION FOR CHECKPOINT IMMUNOTHERAPY. Neuro Oncol.
Citação norma ChicagoAmpudia-Mesias, Elisabet, Christopher Moertel, and Michael Olin. "IMMU-02. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT: A NEW DIRECTION FOR CHECKPOINT IMMUNOTHERAPY." Neuro Oncol 2017.
ציטוט MLAAmpudia-Mesias, Elisabet, Christopher Moertel, and Michael Olin. "IMMU-02. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT: A NEW DIRECTION FOR CHECKPOINT IMMUNOTHERAPY." Neuro Oncol 2017.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.